Strontium ranelate in the treatment of osteoporosis

dc.contributor.authorHough S.
dc.date.accessioned2011-05-15T16:16:58Z
dc.date.available2011-05-15T16:16:58Z
dc.date.issued2006
dc.description.abstract[No abstract available]
dc.description.versionEditorial
dc.identifier.citationJournal of Endocrinology, Metabolism and Diabetes of South Africa
dc.identifier.citation11
dc.identifier.citation1
dc.identifier.issn16089677
dc.identifier.urihttp://hdl.handle.net/10019.1/14012
dc.subjectalendronic acid
dc.subjectbisphosphonic acid derivative
dc.subjectestrogen derivative
dc.subjectfluoride
dc.subjectparathyroid hormone[1-34]
dc.subjectplacebo
dc.subjectstrontium ranelate
dc.subjectbone density
dc.subjectcell activity
dc.subjectcell differentiation
dc.subjectcell proliferation
dc.subjectclinical trial
dc.subjectdermatitis
dc.subjectdiarrhea
dc.subjectdrug blood level
dc.subjectdrug efficacy
dc.subjectdrug mechanism
dc.subjectdrug safety
dc.subjectdrug tolerability
dc.subjectdual energy X ray absorptiometry
dc.subjecteditorial
dc.subjectfragility fracture
dc.subjectgastrointestinal toxicity
dc.subjectheadache
dc.subjecthuman
dc.subjectnausea
dc.subjectnonhuman
dc.subjectossification
dc.subjectosteoblast
dc.subjectosteoclast
dc.subjectosteolysis
dc.subjectosteomalacia
dc.subjectosteopenia
dc.subjectosteoporosis
dc.subjectpostmenopause osteoporosis
dc.subjectthromboembolism
dc.subjecttreatment outcome
dc.titleStrontium ranelate in the treatment of osteoporosis
dc.typeEditorial
Files